5-1432571-G-A

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_001044.5(SLC6A3):​c.546C>T​(p.Asn182Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00363 in 1,614,252 control chromosomes in the GnomAD database, including 48 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0038 ( 6 hom., cov: 33)
Exomes 𝑓: 0.0036 ( 42 hom. )

Consequence

SLC6A3
NM_001044.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 3.25

Publications

0 publications found
Variant links:
Genes affected
SLC6A3 (HGNC:11049): (solute carrier family 6 member 3) This gene encodes a dopamine transporter which is a member of the sodium- and chloride-dependent neurotransmitter transporter family. The 3' UTR of this gene contains a 40 bp tandem repeat, referred to as a variable number tandem repeat or VNTR, which can be present in 3 to 11 copies. Variation in the number of repeats is associated with idiopathic epilepsy, attention-deficit hyperactivity disorder, dependence on alcohol and cocaine, susceptibility to Parkinson disease and protection against nicotine dependence.[provided by RefSeq, Nov 2009]
SLC6A3 Gene-Disease associations (from GenCC):
  • classic dopamine transporter deficiency syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • SLC6A3-related dopamine transporter deficiency syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • parkinsonism-dystonia, infantile
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 5-1432571-G-A is Benign according to our data. Variant chr5-1432571-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 470639.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=3.26 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00378 (576/152372) while in subpopulation NFE AF = 0.00328 (223/68026). AF 95% confidence interval is 0.00293. There are 6 homozygotes in GnomAd4. There are 368 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC6A3NM_001044.5 linkc.546C>T p.Asn182Asn synonymous_variant Exon 4 of 15 ENST00000270349.12 NP_001035.1 Q01959

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC6A3ENST00000270349.12 linkc.546C>T p.Asn182Asn synonymous_variant Exon 4 of 15 1 NM_001044.5 ENSP00000270349.9 Q01959
SLC6A3ENST00000713696.1 linkc.546C>T p.Asn182Asn synonymous_variant Exon 4 of 15 ENSP00000519000.1
SLC6A3ENST00000713698.1 linkc.546C>T p.Asn182Asn synonymous_variant Exon 4 of 5 ENSP00000519002.1
SLC6A3ENST00000713697.1 linkn.546C>T non_coding_transcript_exon_variant Exon 4 of 11 ENSP00000519001.1

Frequencies

GnomAD3 genomes
AF:
0.00378
AC:
576
AN:
152254
Hom.:
6
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000747
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000413
Gnomad FIN
AF:
0.0296
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00328
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00449
AC:
1128
AN:
251456
AF XY:
0.00430
show subpopulations
Gnomad AFR exome
AF:
0.000431
Gnomad AMR exome
AF:
0.000492
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0292
Gnomad NFE exome
AF:
0.00364
Gnomad OTH exome
AF:
0.00326
GnomAD4 exome
AF:
0.00362
AC:
5291
AN:
1461880
Hom.:
42
Cov.:
33
AF XY:
0.00353
AC XY:
2564
AN XY:
727244
show subpopulations
African (AFR)
AF:
0.000388
AC:
13
AN:
33476
American (AMR)
AF:
0.000581
AC:
26
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00139
AC:
120
AN:
86258
European-Finnish (FIN)
AF:
0.0278
AC:
1485
AN:
53418
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00312
AC:
3474
AN:
1112008
Other (OTH)
AF:
0.00286
AC:
173
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
347
694
1041
1388
1735
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
128
256
384
512
640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00378
AC:
576
AN:
152372
Hom.:
6
Cov.:
33
AF XY:
0.00494
AC XY:
368
AN XY:
74510
show subpopulations
African (AFR)
AF:
0.000745
AC:
31
AN:
41596
American (AMR)
AF:
0.000196
AC:
3
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4834
European-Finnish (FIN)
AF:
0.0296
AC:
314
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00328
AC:
223
AN:
68026
Other (OTH)
AF:
0.00142
AC:
3
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
29
57
86
114
143
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00294
Hom.:
2
Bravo
AF:
0.00150
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Classic dopamine transporter deficiency syndrome Benign:3
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 28, 2017
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 19, 2015
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SLC6A3: BP4, BS2 -

Jun 16, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Parkinsonism-dystonia, infantile Benign:1
Jan 07, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.46
CADD
Benign
8.5
DANN
Benign
0.76
PhyloP100
3.3
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28364996; hg19: chr5-1432686; API